MAPKAPK2 and inflammatory bowel disease: In the present study, we used MK2Lyz2−KO mice, a mouse strain with MK2 conditional deficiency in myeloid lineage cells, to identify whether the inhibition targeting MK2 in myeloid lineage cells could ameliorate IBD and affect neutrophils releasing ROS and to explore the potential mechanisms.